Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 26.96 CNY -3.54%
Market Cap: 6.4B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sirio Pharma Co Ltd

Current Assets 1.9B
Cash & Short-Term Investments 583.9m
Receivables 714.3m
Other Current Assets 571m
Non-Current Assets 3.3B
Long-Term Investments 75m
PP&E 2B
Intangibles 981.3m
Other Non-Current Assets 255.4m
Current Liabilities 751.4m
Accounts Payable 402.3m
Accrued Liabilities 129.9m
Short-Term Debt 56.5m
Other Current Liabilities 162.6m
Non-Current Liabilities 2.1B
Long-Term Debt 1.4B
Other Non-Current Liabilities 732.2m

Balance Sheet
Sirio Pharma Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
270
111
72
72
217
709
1 389
522
Cash
0
0
0
0
0
709
1 389
522
Cash Equivalents
270
111
72
72
217
0
0
0
Short-Term Investments
0
0
0
433
474
531
188
221
Total Receivables
377
188
251
260
342
416
490
669
Accounts Receivables
122
160
208
187
261
342
460
613
Other Receivables
255
28
43
73
81
74
31
56
Inventory
157
193
228
204
267
240
233
481
Other Current Assets
17
17
18
347
25
19
132
41
Total Current Assets
820
509
569
1 317
1 324
1 915
2 433
1 933
PP&E Net
302
401
589
639
786
1 179
1 339
1 961
PP&E Gross
302
401
589
639
786
1 179
1 339
1 961
Accumulated Depreciation
277
326
363
415
474
522
639
847
Intangible Assets
172
176
171
180
176
208
217
578
Goodwill
161
171
172
172
176
159
163
421
Long-Term Investments
0
0
0
0
152
338
0
94
Other Long-Term Assets
19
31
42
53
36
22
35
209
Other Assets
161
171
172
172
176
159
163
421
Total Assets
1 475
N/A
1 288
-13%
1 544
+20%
2 359
+53%
2 650
+12%
3 820
+44%
4 186
+10%
5 196
+24%
Liabilities
Accounts Payable
93
119
145
143
200
196
259
392
Accrued Liabilities
33
33
37
32
69
47
61
197
Short-Term Debt
242
100
166
35
2
0
0
6
Current Portion of Long-Term Debt
18
51
107
32
33
5
7
64
Other Current Liabilities
407
110
67
59
84
85
142
92
Total Current Liabilities
792
412
522
301
387
332
470
751
Long-Term Debt
147
223
158
32
0
869
929
1 305
Deferred Income Tax
0
0
8
12
15
12
23
28
Minority Interest
0
0
0
0
0
0
0
176
Other Liabilities
74
73
72
68
65
61
62
545
Total Liabilities
1 013
N/A
708
-30%
760
+7%
414
-45%
467
+13%
1 275
+173%
1 484
+16%
2 806
+89%
Equity
Common Stock
60
60
60
80
120
180
180
182
Retained Earnings
271
399
603
745
978
1 138
1 278
1 496
Additional Paid In Capital
132
114
114
1 113
1 081
1 045
1 048
548
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
45
Other Equity
1
7
7
7
4
182
195
210
Total Equity
462
N/A
580
+26%
784
+35%
1 945
+148%
2 183
+12%
2 545
+17%
2 702
+6%
2 390
-12%
Total Liabilities & Equity
1 475
N/A
1 288
-13%
1 544
+20%
2 359
+53%
2 650
+12%
3 820
+44%
4 186
+10%
5 196
+24%
Shares Outstanding
Common Shares Outstanding
135
135
135
180
180
234
235
233

See Also

Discover More